2020 Q3 Form 10-Q Financial Statement
#000180136820000009 Filed on November 04, 2020
Income Statement
Concept | 2020 Q3 |
---|---|
Revenue | $41.02M |
YoY Change | |
Cost Of Revenue | |
YoY Change | |
Gross Profit | |
YoY Change | |
Gross Profit Margin | |
Selling, General & Admin | $3.100M |
YoY Change | |
% of Gross Profit | |
Research & Development | |
YoY Change | |
% of Gross Profit | |
Depreciation & Amortization | $2.179M |
YoY Change | |
% of Gross Profit | |
Operating Expenses | $3.100M |
YoY Change | |
Operating Profit | $16.15M |
YoY Change | |
Interest Expense | $1.713M |
YoY Change | |
% of Operating Profit | 10.6% |
Other Income/Expense, Net | $61.00K |
YoY Change | |
Pretax Income | $14.50M |
YoY Change | |
Income Tax | -$125.0K |
% Of Pretax Income | -0.86% |
Net Earnings | $14.63M |
YoY Change | |
Net Earnings / Revenue | 35.66% |
Basic Earnings Per Share | $0.20 |
Diluted Earnings Per Share | $0.20 |
COMMON SHARES | |
Basic Shares Outstanding | 71.94M shares |
Diluted Shares Outstanding | 71.94M shares |
Balance Sheet
Concept | 2020 Q3 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | $900.0K |
YoY Change | |
Cash & Equivalents | $30.24M |
Short-Term Investments | |
Other Short-Term Assets | $300.0K |
YoY Change | |
Inventory | |
Prepaid Expenses | $334.5K |
Receivables | |
Other Receivables | |
Total Short-Term Assets | $1.243M |
YoY Change | |
LONG-TERM ASSETS | |
Property, Plant & Equipment | |
YoY Change | |
Goodwill | |
YoY Change | |
Intangibles | |
YoY Change | |
Long-Term Investments | $345.1M |
YoY Change | |
Other Assets | |
YoY Change | |
Total Long-Term Assets | $345.1M |
YoY Change | |
TOTAL ASSETS | |
Total Short-Term Assets | $1.243M |
Total Long-Term Assets | $345.1M |
Total Assets | $346.3M |
YoY Change | |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | $3.400M |
YoY Change | |
Accrued Expenses | $100.0K |
YoY Change | |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | $0.00 |
YoY Change | |
Long-Term Debt Due | |
YoY Change | |
Total Short-Term Liabilities | $3.533M |
YoY Change | |
LONG-TERM LIABILITIES | |
Long-Term Debt | $0.00 |
YoY Change | |
Other Long-Term Liabilities | $12.10M |
YoY Change | |
Total Long-Term Liabilities | $12.10M |
YoY Change | |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $3.533M |
Total Long-Term Liabilities | $12.10M |
Total Liabilities | $15.61M |
YoY Change | |
SHAREHOLDERS EQUITY | |
Retained Earnings | -$3.389M |
YoY Change | |
Common Stock | |
YoY Change | |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | |
YoY Change | |
Treasury Stock Shares | |
Shareholders Equity | -$10.12M |
YoY Change | |
Total Liabilities & Shareholders Equity | $346.3M |
YoY Change |
Cashflow Statement
Concept | 2020 Q3 |
---|---|
OPERATING ACTIVITIES | |
Net Income | $14.63M |
YoY Change | |
Depreciation, Depletion And Amortization | $2.179M |
YoY Change | |
Cash From Operating Activities | -$480.0K |
YoY Change | |
INVESTING ACTIVITIES | |
Capital Expenditures | |
YoY Change | |
Acquisitions | |
YoY Change | |
Other Investing Activities | $0.00 |
YoY Change | |
Cash From Investing Activities | $0.00 |
YoY Change | |
FINANCING ACTIVITIES | |
Cash Dividend Paid | |
YoY Change | |
Common Stock Issuance & Retirement, Net | |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | -40.00K |
YoY Change | |
NET CHANGE | |
Cash From Operating Activities | -480.0K |
Cash From Investing Activities | 0.000 |
Cash From Financing Activities | -40.00K |
Net Change In Cash | -520.0K |
YoY Change | |
FREE CASH FLOW | |
Cash From Operating Activities | -$480.0K |
Capital Expenditures | |
Free Cash Flow | |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2020 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001801368 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2020Q2 | fvac |
Number Of Redeemable Warrants In Each Unit Issued In Public Offering
NumberOfRedeemableWarrantsInEachUnitIssuedInPublicOffering
|
0.3333 | shares |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2020-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-39277 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
FORTRESS VALUE ACQUISITION CORP. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
84-4465489 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1345 Avenue of the Americas | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10105 | ||
dei |
City Area Code
CityAreaCode
|
212 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
798-6100 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2020Q3 | us-gaap |
Cash
Cash
|
909007 | USD |
CY2020Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
334489 | USD |
CY2020Q3 | us-gaap |
Assets Current
AssetsCurrent
|
1243496 | USD |
CY2020Q3 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
345068821 | USD |
CY2020Q3 | us-gaap |
Assets
Assets
|
346312317 | USD |
CY2020Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
3396213 | USD |
CY2020Q3 | fvac |
Franchise Tax Payable Current
FranchiseTaxPayableCurrent
|
137046 | USD |
CY2020Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3533259 | USD |
CY2020Q3 | fvac |
Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
|
12075000 | USD |
CY2020Q3 | us-gaap |
Liabilities
Liabilities
|
15608259 | USD |
CY2020Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2020Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2020Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2020Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2020Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
8387826 | USD |
CY2020Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3388874 | USD |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5000008 | USD |
CY2020Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
346312317 | USD |
CY2020Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3048747 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3320649 | USD | |
CY2020Q3 | fvac |
Franchise Tax Expense
FranchiseTaxExpense
|
50232 | USD |
fvac |
Franchise Tax Expense
FranchiseTaxExpense
|
137046 | USD | |
CY2020Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3098979 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3457695 | USD | |
CY2020Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
31946 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
68821 | USD | |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3067033 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3388874 | USD | |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | USD |
CY2020Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5500 | USD |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
19500 | USD |
CY2020Q2 | fvac |
Sale Of Units In Initial Public Offering Net Of Offering Costs Par Value
SaleOfUnitsInInitialPublicOfferingNetOfOfferingCostsParValue
|
325167932 | USD |
CY2020Q2 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
8900000 | USD |
CY2020Q2 | us-gaap |
Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
|
-328771090 | USD |
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-316341 | USD |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5000001 | USD |
CY2020Q3 | us-gaap |
Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
|
3067040 | USD |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3067033 | USD |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5000008 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3388874 | USD | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
68821 | USD | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
334489 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2785762 | USD | |
fvac |
Increase Decrease In Franchise Tax Payable
IncreaseDecreaseInFranchiseTaxPayable
|
137046 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-869376 | USD | |
us-gaap |
Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
|
345000000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-345000000 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
25000 | USD | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
211382 | USD | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
211382 | USD | |
fvac |
Proceeds From Issuance Initial Public Offering Net Of Underwriting Commission
ProceedsFromIssuanceInitialPublicOfferingNetOfUnderwritingCommission
|
338100000 | USD | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
246617 | USD | |
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
8900000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
346778383 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
909007 | USD | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | USD |
CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
909007 | USD |
fvac |
Offering Costs Accounts Payable And Accrued Expenses Noncash
OfferingCostsAccountsPayableAndAccruedExpensesNoncash
|
610451 | USD | |
fvac |
Deferred Offering Costs Noncash Financing Activities
DeferredOfferingCostsNoncashFinancingActivities
|
12075000 | USD | |
us-gaap |
Stock Issued1
StockIssued1
|
325704050 | USD | |
CY2020Q2 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
345000000.0 | USD |
CY2020Q2 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
19800000 | USD |
CY2020Q2 | fvac |
Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
|
12100000 | USD |
CY2020Q2 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
8900000 | USD |
CY2020Q2 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
345000000.0 | USD |
CY2020Q2 | fvac |
Investment Securities Maturity Period
InvestmentSecuritiesMaturityPeriod
|
P185D | |
CY2020Q3 | us-gaap |
Cash
Cash
|
900000 | USD |
CY2020Q3 | fvac |
Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance
MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
|
0.80 | |
CY2020Q3 | fvac |
Minimum Percentage Of Voting Interests To Be Acquired In Business Combination
MinimumPercentageOfVotingInterestsToBeAcquiredInBusinessCombination
|
0.50 | |
CY2020Q3 | fvac |
Minimum Net Tangible Assets To Complete Business Combination
MinimumNetTangibleAssetsToCompleteBusinessCombination
|
5000001 | USD |
CY2020Q3 | fvac |
Minimum Net Tangible Assets To Complete Business Combination
MinimumNetTangibleAssetsToCompleteBusinessCombination
|
5000001 | USD |
CY2020Q3 | fvac |
Percentage Of Public Shares Required To Repurchase If Business Combination Is Not Completed Within Specific Period
PercentageOfPublicSharesRequiredToRepurchaseIfBusinessCombinationIsNotCompletedWithinSpecificPeriod
|
1 | |
fvac |
Number Of Fractional Warrants Be Issued
NumberOfFractionalWarrantsBeIssued
|
0 | shares | |
CY2020Q3 | us-gaap |
Cash
Cash
|
900000 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
68821 | USD | |
CY2020Q3 | fvac |
Working Capital Deficiency
WorkingCapitalDeficiency
|
2300000 | USD |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed as of September 30, 2020, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></div> | ||
CY2020Q2 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
19800000 | USD |
CY2020Q2 | fvac |
Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
|
12100000 | USD |
CY2020Q3 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
CY2020Q3 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | USD |
CY2020Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
31946 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
68821 | USD | |
CY2020Q3 | fvac |
Investment Income Interest Income Used To Pay Taxes
InvestmentIncomeInterestIncomeUsedToPayTaxes
|
31946 | USD |
fvac |
Investment Income Interest Income Used To Pay Taxes
InvestmentIncomeInterestIncomeUsedToPayTaxes
|
68821 | USD | |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which at times may exceed the Federal depository insurance coverage of $250,000. As of September 30, 2020, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. | ||
CY2020Q3 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | USD |
CY2020Q2 | fvac |
Number Of Shares In Each Unit
NumberOfSharesInEachUnit
|
1 | shares |
CY2020Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25000 | USD |
fvac |
Common Stock Threshold Trading Days
CommonStockThresholdTradingDays
|
20 | day | |
fvac |
Common Stock Threshold Consecutive Trading Days
CommonStockThresholdConsecutiveTradingDays
|
30 | day | |
fvac |
Class Of Warrant Or Right Blackout Trading Period After Completion Of Business Combination
ClassOfWarrantOrRightBlackoutTradingPeriodAfterCompletionOfBusinessCombination
|
P30D | ||
CY2020Q2 | fvac |
Underwriting Agreement Option Period
UnderwritingAgreementOptionPeriod
|
P45D | |
CY2020Q2 | fvac |
Underwriting Discount
UnderwritingDiscount
|
0.20 | |
CY2020Q2 | fvac |
Underwriting Discount Paid
UnderwritingDiscountPaid
|
6900000 | USD |
CY2020Q2 | fvac |
Deferred Underwriting Discount
DeferredUnderwritingDiscount
|
0.35 | |
CY2020Q2 | fvac |
Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
|
12100000 | USD |
CY2020Q3 | fvac |
Class F Percentageof Total Common Stock Outstanding Upon Completionof Initial Public Offering
ClassFPercentageofTotalCommonStockOutstandingUponCompletionofInitialPublicOffering
|
0.20 | |
CY2020Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2020Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2020Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2020Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
fvac |
Warrants Exercise Period Following Business Combination
WarrantsExercisePeriodFollowingBusinessCombination
|
P30D | ||
fvac |
Warrants Exercise Period Following Initial Public Offering
WarrantsExercisePeriodFollowingInitialPublicOffering
|
P12M | ||
CY2020Q3 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
fvac |
Restriction Period For Transfer Assignment Or Sale
RestrictionPeriodForTransferAssignmentOrSale
|
P30D | ||
fvac |
Redemption Price Per Warrant
RedemptionPricePerWarrant
|
0.01 | ||
fvac |
Numberof Daysfor Written Noticeof Redemption
NumberofDaysforWrittenNoticeofRedemption
|
P30D | ||
fvac |
Minimum Threshold Priceof Common Stock Specifiedto Send Noticeof Redemptiontothe Warrant Holders
MinimumThresholdPriceofCommonStockSpecifiedtoSendNoticeofRedemptiontotheWarrantHolders
|
18.00 | ||
fvac |
Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price
PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice
|
9.20 | ||
CY2020Q3 | fvac |
Percentageof Warrant Exercise Price Adjustedto Price Receivedin New Issuance
PercentageofWarrantExercisePriceAdjustedtoPriceReceivedinNewIssuance
|
1.15 |